- Tytuł:
-
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (
ANRS 12 300Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial. - Autorzy:
- Źródło:
- Lancet Infectious Diseases. Jun2021, Vol. 21 Issue 6, p813-822. 10p.
Czasopismo naukowe